The third symposium on stem cell and cell therapies in lung diseases will be held by the support of stem cells sciences and technologies development headquarter.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, there are many researches on the use of stem cell transplantation in pulmonary diseases, but because lung organs are susceptible to other organs, animal specimens are currently being examined and there is a long way for human models.

In this regard, the third symposium on stem cell and cell therapies in lung diseases will be held July 26^th 2018 in pediatric healthcare center by the support of stem cells sciences and technologies development headquarter.

The main topics of the event include stem cell transplantation in pulmonary fibrosis, increased pulmonary pressures, stem cell transplantation in pulmonary inflammatory diseases, the use of stem cells in pediatric lung hypertension, the use of stem cells in cystic fibrosis, the challenges of using stem cells in pulmonary diseases, post-transplant care Stem cells in pulmonary diseases; the position of using stem cells in resistant lung infections in children as well as stem cell transplantation ethics.

The symposium on stem cell and its use in lung diseases is a one-day symposium with five re-training scores. This event will be held with the support of the stem cell sciences and technologies development headquarter.